Status:
COMPLETED
Serum Uromodulin and DN Systematic Review and Meta Analysis
Lead Sponsor:
Tanta University
Collaborating Sponsors:
Ain Shams University
Conditions:
Diabetic Nephropathies
Eligibility:
All Genders
Brief Summary
Several studies have investigated the association between the changes of serum uromodulin and diabetic nephropathy (DN). However, the results are still controversial. Hence, this meta-analysis aimed t...
Eligibility Criteria
Inclusion
- Studies were included if they met the following criteria:
- serum level of uromodulin was determined;
- the samples were enrolled from diabetic patients;
- mean ± SD was reported for uromodulin between patients with and without DN;
- the level of albumin to creatinine ratio (ACR), glomerular filtration rate (GFR), or albumin excretion rate (AER) in patients with DN was determined
Exclusion
- Studies were excluded according to the following criteria:
- duplicate studies;
- review articles;
- non original research articles;
- studies with insufficient data to extract;
- non-human research;
- studies that determined urine level of uromodulin.
Key Trial Info
Start Date :
May 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 30 2024
Estimated Enrollment :
1774 Patients enrolled
Trial Details
Trial ID
NCT06596863
Start Date
May 1 2024
End Date
May 30 2024
Last Update
September 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tanta Yniversity
Tanta, Yes, Egypt, 31511